Quanterix (United States)

Recent papers from Quanterix (United States)

1. APOE ε4 carriership status enhances age-related changes in Alzheimer’s disease plasma biomarkers concentrationsNature Communications · 2026
2. The second assessment of the commutability of candidate reference materials for the harmonization of blood neurofilament light chain measurementsClinical Chemistry and Laboratory Medicine (CCLM) · 2026
3. Plasma Alzheimer Biomarkers and Diagnostic Decision-Making in Memory ClinicsJAMA Network Open · 2026
4. Towards a neurophysiological diagnostic marker of Alzheimer's disease using transcranial magnetic stimulation combined with electroencephalographyJournal of Alzheimer s Disease · 2026
5. Comparison of a multi‐analyte algorithmic immunoassay blood test with immunoprecipitation mass spectrometry for the detection of amyloid pathologyAlzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2026
6. Profiling Protein Aggregate Size Using Single-Molecule Array TechnologyAnalytical Chemistry · 2026
7. Blood-Based Biomarkers Predict Differential Longitudinal Decline in Alzheimer’s Disease Psychosis: Evidence from Two Cohorts2026
8. Motor Network Neurophysiological (TMS-EEG) Markers as Predictors of Long-term Outcomes Following Ventriculoperitoneal Shunt in Normal Pressure Hydrocephalus (P10-16.001)Neurology · 2026
9. Blood-based Quantitation of p-Tau Proteins, BD-tau, and Inflammatory Cytokines in Alzheimer’s Disease (P10-12.008)Neurology · 2026
10. Prefrontal and Occipital Network Excitability Differences in Dementia with Lewy Bodies and Alzheimer's DiseaseClinical EEG and Neuroscience · 2026
11. Model‐Based Meta‐Analysis of Overall Survival in Vulnerable Platinum‐Ineligible NSCLC PopulationsCPT Pharmacometrics & Systems Pharmacology · 2026
12. Individualized prediction of clinical progression to dementia using plasma biomarkers in non-demented elderlyAlzheimer s Research & Therapy · 2025
13. Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI)Journal for ImmunoTherapy of Cancer · 2025
14. Genetic and environmental contributions to variation in plasma phosphorylated tau 217Alzheimer s & Dementia · 2025
15. Genetic and environmental contributions to variation in plasma phosphorylated tau 217Alzheimer s & Dementia · 2025
16. Clinical performance of scalable automated p‐tau 217 multi‐analyte algorithmic blood test with reduced intermediate zone using multiplexed digital immunoassayAlzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2025
17. 33 Unresolved Questions in Nanoscience and NanotechnologyACS Nano · 2025
18. Analytical and clinical validation of a high accuracy fully automated digital immunoassay for plasma phospho-Tau 217 for clinical use in detecting amyloid pathologyFrontiers in Neurology · 2025
19. Clinical Performance of LucentAD Complete: A Multi-Analyte Algorithmic Blood Test for Detecting Brain Amyloid with a Scalable, Multiplexed Digital Immunoassay2025
20. The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho‐tau Round Robin studyAlzheimer s & Dementia · 2025